Quarterly report · Q2

Period2022-04-01 → 2022-09-30
Filed2022-11-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥1.2bn2022-04-01 → 2022-09-30Cons.Net sales
Revenue¥2.4bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥1.1bn2021-04-01 → 2021-09-30Cons.Net sales
Operating income¥94m2022-04-01 → 2022-09-30Cons.Operating income
Operating income¥116m2021-04-01 → 2021-09-30Cons.Operating income
Ordinary income¥120m2022-04-01 → 2022-09-30Cons.Ordinary income
Ordinary income¥352m2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥131m2021-04-01 → 2021-09-30Cons.Ordinary income
Profit before tax¥119m2022-04-01 → 2022-09-30Cons.Income before income taxes
Profit before tax¥131m2021-04-01 → 2021-09-30Cons.Income before income taxes
Net income (owners)¥82m2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥340m2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥113m2021-04-01 → 2021-09-30Cons.Profit loss attributable to owners of parent
Net income¥82m2022-04-01 → 2022-09-30Cons.Profit loss
Net income¥113m2021-04-01 → 2021-09-30Cons.Profit loss
Total assets¥4.4bnat 2022-09-30Cons.Assets
Total assets¥4.6bnat 2022-03-31Cons.Assets
Total assets¥4.1bnat 2021-09-30Cons.Total assets (5-year summary)
Total liabilities¥1.1bnat 2022-09-30Cons.Liabilities
Total liabilities¥1.4bnat 2022-03-31Cons.Liabilities
Net assets / equity¥3.3bnat 2022-09-30Cons.Net assets
Net assets / equity¥3.3bnat 2022-03-31Cons.Net assets
Net assets / equity¥3.0bnat 2021-09-30Cons.Net assets (5-year summary)
Cash and deposits¥1.9bnat 2022-09-30Cons.Cash and deposits
Cash and deposits¥2.2bnat 2022-03-31Cons.Cash and deposits
Cash & equivalents¥1.9bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥2.2bnat 2022-03-31Cons.Cash and cash equivalents
Cash & equivalents¥1.9bnat 2021-09-30Cons.Cash and cash equivalents
Cash & equivalents¥1.7bnat 2021-03-31dCons.Cash and cash equivalents
Operating cash flow−¥191m2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥659m2021-04-01 → 2022-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥295m2021-04-01 → 2021-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥19m2022-04-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥66m2021-04-01 → 2022-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥37m2021-04-01 → 2021-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥130m2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥72m2021-04-01 → 2022-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥66m2021-04-01 → 2021-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥60.112022-04-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥73.992022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥248.752021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥82.612021-04-01 → 2021-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥802021-07-01 → 2021-09-30dCons.Basic earnings loss per share (5-year summary)
Equity ratio74.2%at 2022-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio70.4%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio73.9%at 2021-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 24
SegmentItemPeriodValue
jpcrp040300-q2r_E02021-000Healthcare Related Productsreportable segmentrevenue2022-04-01 → 2022-09-30¥556m
jpcrp040300-q2r_E02021-000Healthcare Related Productsreportable segmentrevenue external2022-04-01 → 2022-09-30¥556m
jpcrp040300-q2r_E02021-000Healthcare Related Productsreportable segmentsegment profit2022-04-01 → 2022-09-30¥48m
jpcrp040300-q2r_E02021-000Optical Applications And Special Customized Productsreportable segmentrevenue2022-04-01 → 2022-09-30¥335m
jpcrp040300-q2r_E02021-000Optical Applications And Special Customized Productsreportable segmentrevenue external2022-04-01 → 2022-09-30¥335m
jpcrp040300-q2r_E02021-000Optical Applications And Special Customized Productsreportable segmentsegment profit2022-04-01 → 2022-09-30¥103m
jpcrp040300-q2r_E02021-000X Ray Residual Stress Analyzerreportable segmentrevenue2022-04-01 → 2022-09-30¥288m
jpcrp040300-q2r_E02021-000X Ray Residual Stress Analyzerreportable segmentrevenue external2022-04-01 → 2022-09-30¥288m
jpcrp040300-q2r_E02021-000X Ray Residual Stress Analyzerreportable segmentsegment profit2022-04-01 → 2022-09-30¥84m
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-09-30¥1.2bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-09-30¥1.2bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-09-30¥234m
jpcrp040300-q2r_E02021-000Healthcare Related Productsreportable segmentrevenue2021-04-01 → 2021-09-30¥530m
jpcrp040300-q2r_E02021-000Healthcare Related Productsreportable segmentrevenue external2021-04-01 → 2021-09-30¥530m
jpcrp040300-q2r_E02021-000Healthcare Related Productsreportable segmentsegment profit2021-04-01 → 2021-09-30¥100m
jpcrp040300-q2r_E02021-000Optical Applications And Special Customized Productsreportable segmentrevenue2021-04-01 → 2021-09-30¥321m
jpcrp040300-q2r_E02021-000Optical Applications And Special Customized Productsreportable segmentrevenue external2021-04-01 → 2021-09-30¥321m
jpcrp040300-q2r_E02021-000Optical Applications And Special Customized Productsreportable segmentsegment profit2021-04-01 → 2021-09-30¥84m
jpcrp040300-q2r_E02021-000X Ray Residual Stress Analyzerreportable segmentrevenue2021-04-01 → 2021-09-30¥257m
jpcrp040300-q2r_E02021-000X Ray Residual Stress Analyzerreportable segmentrevenue external2021-04-01 → 2021-09-30¥257m
jpcrp040300-q2r_E02021-000X Ray Residual Stress Analyzerreportable segmentsegment profit2021-04-01 → 2021-09-30¥78m
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-09-30¥1.1bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-09-30¥1.1bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-09-30¥262m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 420
ItemContextValueUnit
Independent auditors report consolidated (text)FilingDateInstantText · Plus
Audit firm1 consolidatedFilingDateInstant
Original text (Japanese)ときわ監査法人
Cpa1 audit firm1 consolidatedFilingDateInstant
Original text (Japanese)藤田 将司
Cpa2 audit firm1 consolidatedFilingDateInstant
Original text (Japanese)佐藤  豪
Number of submissionFilingDateInstant1
Net sales (5-year summary)Prior1YTDDuration1108350000JPY
Net sales (5-year summary)CurrentYTDDuration1178700000JPY
Net sales (5-year summary)Prior1YearDuration2445227000JPY
Ordinary income loss (5-year summary)Prior1YTDDuration130549000JPY
Ordinary income loss (5-year summary)CurrentYTDDuration120084000JPY
Ordinary income loss (5-year summary)Prior1YearDuration351591000JPY
Profit loss attributable to owners of parent (5-year summary)Prior1YTDDuration113052000JPY
Profit loss attributable to owners of parent (5-year summary)CurrentYTDDuration82254000JPY
Profit loss attributable to owners of parent (5-year summary)Prior1YearDuration340407000JPY
Comprehensive income (5-year summary)Prior1YTDDuration111183000JPY
Comprehensive income (5-year summary)CurrentYTDDuration94254000JPY
Comprehensive income (5-year summary)Prior1YearDuration340495000JPY
Net assets (5-year summary)Prior1QuarterInstant3044566000JPY
Net assets (5-year summary)CurrentQuarterInstant3251484000JPY
Net assets (5-year summary)Prior1YearInstant3273619000JPY
Total assets (5-year summary)Prior1QuarterInstant4120307000JPY
Total assets (5-year summary)CurrentQuarterInstant4379816000JPY
Total assets (5-year summary)Prior1YearInstant4647882000JPY
Basic earnings loss per share (5-year summary)Prior1YTDDuration82.61
Basic earnings loss per share (5-year summary)CurrentYTDDuration60.11
Basic earnings loss per share (5-year summary)Prior1YearDuration248.75
Diluted earnings per share (5-year summary)Prior1YTDDuration-
Diluted earnings per share (5-year summary)CurrentYTDDuration-
Diluted earnings per share (5-year summary)Prior1YearDuration-
Equity to asset ratio (5-year summary)Prior1QuarterInstant0.739
Equity to asset ratio (5-year summary)CurrentQuarterInstant0.742
Equity to asset ratio (5-year summary)Prior1YearInstant0.704
Net cash provided by used in operating activities (5-year summary)Prior1YTDDuration294740000JPY
Net cash provided by used in operating activities (5-year summary)CurrentYTDDuration-190813000JPY
Net cash provided by used in operating activities (5-year summary)Prior1YearDuration658531000JPY
Net cash provided by used in investing activities (5-year summary)Prior1YTDDuration-36803000JPY
Net cash provided by used in investing activities (5-year summary)CurrentYTDDuration-19322000JPY
Net cash provided by used in investing activities (5-year summary)Prior1YearDuration-66295000JPY
Net cash provided by used in financing activities (5-year summary)Prior1YTDDuration-66433000JPY
Net cash provided by used in financing activities (5-year summary)CurrentYTDDuration-130260000JPY
Net cash provided by used in financing activities (5-year summary)Prior1YearDuration-71905000JPY
Cash and cash equivalents (5-year summary)Prior1QuarterInstant1870735000JPY
Cash and cash equivalents (5-year summary)CurrentQuarterInstant1884904000JPY
Cash and cash equivalents (5-year summary)Prior1YearInstant2212632000JPY
Basic earnings loss per share (5-year summary)Prior1QuarterDuration80.00
Basic earnings loss per share (5-year summary)CurrentQuarterDuration73.99
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember1393459
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember1393459
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant1393459
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant1393459

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-09-30pass